Avid Bioservices Inc (CDMO)

[sunstar]

I was reading an article about the pressure to do deals in pharma.

Many here focus only on our little biotech, Peregrine. But there is substantial and a critically important need to accomplish deals on the big pharma side too.

Take a look at the PFE chart over the seven years. Are those investors pleased? What’s up (or not up) for Pfizer? Pipeline? Income?

http://www.minyanville.com/articles/Amgen-oncology-Biotech-Pfizer-Johnson+%26+Johnson-DOR+Biopharma-cancer/index/a/14557


"Pfizer (PFE ), Johnson & Johnson (JNJ), and others in the big pharma space are reporting dismal quarters. No surprise to me on this account. The issues I've been harping about for a (very) long time – expiring patents, poor pipelines, pricing pressures – are increasingly showing up on pharma's bottom lines. Acquisition and partnership deals are heating up, and will only get hotter over the next six-nine months."

A good reason for being:

>>not aggressive but "proactive."<<

sunstar